Clinical Trial to Compare Two Surgical Approaches to the Cochlea

Phase

N/A

Condition

Deafness

Hearing Impairment

Hearing Loss

Treatment

Surgical approach: cochleostomy or extended round window

Clinical Study ID

NCT06453343

NL85808.091.23

Ages > 18
All Genders

Study Summary

This is a prospective multicenter multinational randomized control trial. The duration of the study for the individual patient will be approximately 1 year (pre-operative assessments, 1 week, 3 months and 12 months follow-up assessments). Participants will be randomized to one of two surgical approaches: eRW or CO, with a 1:1 allocation in a parallel design.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Individuals aged 18 years and older who have clinically established post-linguisticsensorineural hearing loss.
CI candidate based on local or national reimbursement criteria.
Cochlear implantation with a CI632.
Preoperative 500 Hz pure-tone air conduction threshold <80 dB hearing level (HL) inthe ear to be implanted.
Willing and able to provide written informed consent.

Exclusion

Exclusion Criteria:

Previous or existing CI recipient.
Ossification or other anatomical abnormalities of the cochlea or its windowspossibly affecting normal electrode array insertion.
Abnormal cochlear nerve anatomy on preoperative CT or MRI.
Subjects who are unable to undergo CT or MRI.
Deafness due to acoustic nerve or central auditory pathway lesions.
Diagnosis of auditory neuropathy.
Active middle ear infection.
Additional handicaps that would prevent participation in study evaluations.
Unrealistic expectations from the participant regarding the possible benefits,risks, and limitations inherent to the CI procedure and the investigation.
Cochlear employees or employees of Contract Research Organisations or contractorsengaged by Cochlear for the purposes of this investigation.

Study Design

Surgical approach: cochleostomy or extended round window

January 01, 2025

November 30, 2027

Study Description

Rationale: Preserving residual hearing in cochlear implant (CI) surgery has gained significant attention. It not only signifies minimally invasive implantation but also supports natural sound perception and enables electrical-acoustic stimulation, enhancing sound localization, music appreciation, and speech recognition in noisy environments. Using the Cochlear™ Nucleus® CI with Slim Modiolar electrode (Cochlear Ltd., Sydney, Australia), potential sites of residual hearing loss in surgery include approaches to the cochlear lumen, potential damage during entry, and damage during electrode insertion. Studies comparing different surgical approaches (cochleostomy (CO) and extended round window (eRW)) show varied results. Electrocochleography (ECochG) can be used to indicate intracochlear damage during electrode insertion, however, the variability observed in ECochG responses during cochlear implantation remains significant. Moreover, ECochG has not yet been used to monitor cochlear functions throughout every phase of surgery, including the insertion of the sheath or stabilization of the electrode lead.

Objective: The aim of this study is to investigate whether the type of surgical approach to the cochlea; CO or eRW using the CI632 affects the final residual hearing and secondarily, intracochlear trauma and electrode position, as determined by pure tone audiometry, EcochG and imaging.

Study population: Adult CI candidates with post-lingual onset of severe to profound hearing loss, who are scheduled to receive a Nucleus CI632 with a slim modiolar electrode array and have a preoperative audiometric low-frequency average air conduction threshold of <80 decibel (dB) hearing level at 500 Hz in the ear to be implanted.

Connect with a study center

Radboud University Medical Center
Nijmegen,
Netherlands
Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.